Plunkett Research Online: Aptose Biosciences Inc

APTOSE BIOSCIENCES INC (APTO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enh.....



Aptose Biosciences Inc
Ticker: APTO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 647-479-9828
Fax: 905-234-2120
Address: 251 Consumers Road
Suite 1105
Toronto, ON M2J 4R3 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Cancer
Biotechnology
Oncology Therapeutics
Clinical Trials
Contacts Description
William RiceCEO/Chairman of the Board/Director/President
Fletcher PayneCFO/Chief Accounting Officer/Senior VP
See More
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enh.....See More See More

Auditor: KPMG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Luxeptinib (CG-806)
APTO-253
APL-581
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: